Keyphrases
Regulatory Requirements
100%
Turkey
100%
Brazil
100%
South Africa
100%
Mexico
100%
Regulatory Agencies
100%
India-China
100%
Biosimilar
100%
Biosimilar Development
80%
Marketing Authorization
80%
Authorization Process
40%
Sample Analysis
20%
Quantitative Survey
20%
Flexible Approach
20%
Quantitative Content Analysis
20%
In Vivo Toxicity Study
20%
Biological Products
20%
Regulatory Mechanism
20%
Development Program
20%
Transparent Interaction
20%
Review Criteria
20%
Public Assessment Reports
20%
Analytical Data
20%
Scientific Advice
20%
Data Assessment
20%
Process Efficiency
20%
Open Interaction
20%
Scientific Assessment
20%
Descriptive Statistics
20%
Regulatory Reliance
20%
Quantitative Data Analysis
20%
Licensing Process
20%
Development Criteria
20%
Emerging Economies
20%
Lieu
20%
Non-specific Binding
20%
Engineering
Member Country
100%
Brazil
100%
Regulatory Requirement
100%
Licensing Process
33%
Development Process
33%
Emerging Economy
33%
Simplifies
33%
Pharmacology, Toxicology and Pharmaceutical Science
Biosimilar Agent
100%
Clinical Study
25%
Guanosine Phosphate
12%
Biological Product
12%
Economics, Econometrics and Finance
Regulatory Agency
100%
Descriptive Statistics
20%
Emerging Economies
20%